Cited by 61COVID-19 and healthcare impactsGlobal Cancer Incidence and ScreeningData-Driven Disease Surveillance

Impact of the COVID‐19 pandemic on population‐based cancer registry

Open access
Soerjomataram, Isabelle, Bardot, Aude, Aitken, Joanne, Piñeros, Marion, Znaor, Ariana, Steliarova‐Foucher, Eva, Kohler, Betsy, Bettio, Manola +4 more·2022·International Journal of Cancer

Abstract

The COVID‐19 pandemic has caused disruptions to national health systems and impacted health outcomes worldwide. However, the extent to which surveillance systems, such as population‐based cancer registration, have been affected was not reported. Here we sought to evaluate the effect of the pandemic on registry operations across different areas and development levels worldwide. We investigated the impact of COVID‐19 on three main areas of cancer registry operations: staffing, financing and data collection. An online survey was administered to 750 member registries of the International Association for Cancer Registries. Among 212 responding registries from 90 countries, 65.6% reported a disruption in operations, ranging between 45% in south‐eastern Asia and 87% in the Latin America and Caribbean. Active data collection was disrupted more than case notifications or hybrid methods. In countries categorized with low Human Development Index (HDI), a greater number of registries reported a negative impact (81.3%) than in very high HDI countries (57.8%). This contrast was highest in term of impact on financing: 9/16 (56%) registries in low HDI countries reported a current or an expected decline in funding, compared to 7/108 (7%) in very high HDI countries. With many cancer registries worldwide reporting disruption to their operations during the early COVID‐19 pandemic, urgent actions are needed to ensure their continuity. Governmental commitment to support future registry operations as an asset to disease control, alongside a move toward electronic reporting systems will help to ensure the sustainability of cancer surveillance worldwide.

Integrity signals

Registry

Crossref · 10.1002/ijc.33792

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many cancer registries worldwide reported disruptions to their operations during the first wave of the pandemic, and monthly cancer registrations were clearly reduced for common cancers as a result in many countries.

    “Many cancer registries worldwide reported disruptions to their operations during the first wave of the pandemic, 182,183 and monthly cancer registrations were clearly reduced for common cancers as a result in many countries.”

Cites

Flagged first, then by citations

1 of the 21 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Soerjomataram, I., Bardot, A., Aitken, J., Piñeros, M., Znaor, A., Steliarova‐Foucher, E., Kohler, B., Bettio, M., Matsuda, T., de Camargo Cancela, M., Mery, L., & Bray, F.
Affiliations
  • Centre international de recherche sur le cancer (FR)
  • Cancer Council Queensland (AU)
  • North American Association of Central Cancer Registries (US)
  • European Commission (BE)
  • National Cancer Centre Japan (JP)
  • Division of Surveillance, Instituto Nacional de Cancer (Brazilian National Cancer Institute) Rio de Janeiro Brazil
Corresponding author
Soerjomataram, Isabelle
Venue
International Journal of Cancer
Publisher
Wiley
Published
2021-09-18
Volume
150
Issue
2
Pages
273-278
ISSN
  • 0020-7136 (ISSN-L)
  • 1097-0215
OpenAlex
W3198416797
Cited by
61
References
21
Citations by year
2026: 8 · 2025: 18 · 2024: 20 · 2023: 6 · 2022: 7 · 2021: 2
FWCI
3.19
Type
journal article
Language
en
Open access
Locations
  • International Journal of Cancer (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • World Health Organization
  • Centre International de Recherche sur le Cancer
  • European Commission
  • Joint Research Centre
  • Japan Society for the Promotion of Science (23K21521)
Topics
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Epidemiology › Data-Driven Disease Surveillance
Keywords
COVID-19 pandemic, population-based cancer registry, cancer surveillance, Human Development Index
MeSH terms
COVID-19, Humans, Neoplasms, Surveys and Questionnaires, Registries, Global Health, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review